Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    20961818 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: AquADEKs-2;   Dietary Supplement: control multivitamin
2 Completed Safety and Efficacy of an Antioxidant-rich Multivitamin Supplement in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Dietary Supplement: AquADEK

Indicates status has not been verified in more than two years